CIK 0001133416
- Non-accelerated filer
- Smaller reporting company
GALECTIN THERAPEUTICS INC
Sign in to watch- Ticker
- GALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 043562325
- Phone
- +1 678-620-3186
- Business address
- 4960 PEACHTREE INDUSTRIAL BOULEVARD, SUITE 240, NORCROSS, GA, 30071
- Former names
- PRO PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-24 | Boudes Pol F Chief Medical Officer | Grant or award · Stock Option (right to buy) | +65,000 | 65,000 | ||
| 2024-01-24 | Boudes Pol F Chief Medical Officer | Grant or award · Restricted Stock Unit | +40,000 | 40,000 | ||
| 2023-01-26 | Boudes Pol F Chief Medical Officer | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2022-01-24 | Boudes Pol F Chief Medical Officer | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2021-03-25 | Boudes Pol F Chief Medical Officer | Grant or award · Stock option (right to buy) | +50,000 | 50,000 | ||
| 2021-03-25 | Boudes Pol F Chief Medical Officer | Grant or award · Stock option (right to buy) | +100,000 | 100,000 | ||
| 2020-03-12 | Boudes Pol F Chief Medical Officer | Grant or award · Stock option (right to buy) | +300,000 | 300,000 |
Page 1 of 1 · 7 trades